glp-1 obesity drug study august 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Medications for Weight Loss:

The development of novel techniques for ultra-sensitive -synuclein detection, particularly real-time quaking-induced conversion [108], could improve the accuracy of identifying prodromal PD and serve as reliable biomarkers for treatment response

Active Ingredient Amarasate

We generated fully human antibodies to specifically block GDF8 (trevogrumab) and ActA (garetosmab), and showed that combining these blocking antibodies results in much greater increases in muscle than either of the antibodies individually, with dual blockade matching the muscle growth induced by broader ActRIIA/B pathway blockade in both mice and non-human primates (NHPs) 28,31

The drug isnt the variable that determines whether you lose muscle

Weight loss was stedy for 14 months before plateauing

While it is only FDA approved for the treatment of diabetes, studies have shown it has promise in promoting weight loss, with people losing up to 10 pounds